Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,088,810
-$5,022,975 QoQ
Shares Held
381,111
-11.2% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96.66973663840717.ToString("F0")%
Shared 0.ToString("F0")%
None 3.3302633615928166.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Derivatives in LGND
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$3,233,498
PutShares
34,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. LGND ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in LGND
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,088,810 | 381,111 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $81,111,785 | 429,004 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $65,151,205 | 367,795 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,243,916 | 63,722 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,921,654 | 84,855 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $11,851,753 | 110,609 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,533,871 | 95,253 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,442,942 | 64,597 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,174,814 | 57,111 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,562,023 | 63,876 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,184,872 | 69,841 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $7,699,846 | 106,794 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $4,560,057 | 61,991 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,124,565 | 61,745 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,920,847 | 35,758 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,423,687 | 43,546 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,779,539 | 53,859 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,467,449 | 87,876 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,245,747 | 60,357 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $8,006,927 | 97,836 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,233,498 | 34,000 | Put | Defined | 2021-05-17 | |
| 2021-03-31 | $12,731,519 | 133,871 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,895,364 | 159,500 | Put | Defined | 2021-02-12 | |
| 2020-12-31 | $16,669,251 | 268,686 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,387,127 | 292,400 | Put | Defined | 2020-11-13 | |
| 2020-09-30 | $2,378,540 | 40,000 | Call | Defined | 2020-11-13 | |
| 2020-09-30 | $6,156,493 | 103,534 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,321,309 | 47,600 | Call | Defined | 2020-08-12 | |
| 2020-06-30 | $7,886,364 | 113,025 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $18,546,301 | 265,800 | Put | Defined | 2020-08-12 | |
| 2020-03-31 | $3,601,973 | 79,400 | Put | Defined | 2020-05-15 | |
| 2020-03-31 | $5,324,931 | 117,380 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||